POOLBEG PHARMA (UK) LIMITED
Get an alert when POOLBEG PHARMA (UK) LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£159K
+9.7% vs 2024
Net assets
-£6.8M
-38.5% lowest in 3 filed years
Employees
3
0% vs 2024
Profit before tax
-£1.9M
-0.5% vs 2024
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
Negative shareholders' funds
Net assets
3-year trend · vs Health Care median
Accounts
3-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|---|
| Turnover | — | £17,000 | — | — | |
| Operating profit | -£1,853,000 | -£1,365,000 | -£1,322,000 | +3.2% | |
| Profit before tax | -£2,223,000 | -£1,882,000 | -£1,891,000 | -0.5% | |
| Net profit | — | -£1,843,000 | -£1,891,000 | -2.6% | |
| Cash | £214,000 | £145,000 | £159,000 | +9.7% | |
| Total assets less current liabilities | £2,483,000 | £1,592,000 | £1,346,000 | -15.5% | |
| Net assets | -£3,075,000 | -£4,918,000 | -£6,809,000 | -38.5% | |
| Equity | — | — | — | — | |
| Average employees | 4 | 3 | 3 | 0% | |
| Wages | — | — | — | — | |
| Directors' remuneration | — | — | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Return on capital employed | -74.6% | -85.7% | -98.2% | |
| Gearing (liabilities / total assets) | 210.2% | 377.7% | 520.8% | |
| Current ratio | 3.72x | 2.00x | 0.79x | |
| Interest cover | -4.99x | -2.64x | -2.32x |
Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Margin ratios are hidden where reported turnover is too small relative to profit to yield a meaningful figure — typical of holding companies whose income is mostly subsidiary dividends rather than trading revenue. Sector-distribution context coming next.
Name history
Renamed 1 time since incorporation
- POOLBEG PHARMA (UK) LIMITED 2023-06-22 → present
- ORPH PHARMA IP COMPANY LIMITED 2021-03-19 → 2023-06-22
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- Gravita Audit II Limited
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“After making appropriate enquires, the directors consider that the Company has adequate resources to continue in business for the foreseeable future. Accordingly, they continue to adopt the going concern basis in preparing the Financial Statements.”
Significant events
- “On 31 March 2026, Poolbeg announced that it received formal notification of the grant for its POLB 001 cancer immunotherapy-induced Cytokine Release Syndrome ("CRS") patent application from IP Australia, the Australian patent office.”
- “On 15 April 2026, Poolbeg announced that the UK Medicines and Healthcare products Regulatory Agency ("MHRA") has granted Clinical Trial Authorisation ("CTA") for the POLB 001 TOPICAL trial.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
4 active · 0 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| CROCKETT, Ross | Secretary | 2023-05-09 | — | — |
| FRIEL, Cathal Martin | Director | 2021-03-19 | Nov 1964 | Irish |
| O'CONNELL, Ian Richard | Director | 2023-05-09 | Aug 1987 | Irish |
| SKILLINGTON, Jeremy | Director | 2023-05-09 | Feb 1971 | Irish |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Poolbeg Pharma Plc | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2021-06-18 | Active |
| Open Orphan Plc | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2021-03-19 | Ceased 2021-06-18 |
Filing timeline
Last 20 of 28 total filings
Material constitutional events — rename, articles re-file, resolution
- 2023-06-22 CERTNM Certificate change of name company
- 2023-06-22 CONNOT Change of name notice
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-05-29 | AA | accounts | Accounts with accounts type full | |
| 2026-03-18 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2026-03-18 | CH01 | officers | Change person director company with change date | |
| 2026-03-18 | CH01 | officers | Change person director company with change date | |
| 2025-06-30 | AA | accounts | Accounts with accounts type full | |
| 2025-03-18 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-08-21 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2024-07-01 | AD01 | address | Change registered office address company with date old address new address | |
| 2024-07-01 | AD01 | address | Change registered office address company with date old address new address | |
| 2024-06-22 | AA | accounts | Accounts with accounts type full | |
| 2024-03-25 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-10-10 | AA | accounts | Accounts with accounts type full | |
| 2023-06-22 | CERTNM | change-of-name | Certificate change of name company | |
| 2023-06-22 | CONNOT | change-of-name | Change of name notice | |
| 2023-05-12 | AP03 | officers | Appoint person secretary company with name date | |
| 2023-05-12 | AP01 | officers | Appoint person director company with name date | |
| 2023-05-12 | AP01 | officers | Appoint person director company with name date | |
| 2023-03-27 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-04-08 | AA | accounts | Accounts with accounts type full | |
| 2022-03-25 | CS01 | confirmation-statement | Confirmation statement with updates |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 4
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.